Synonyms: LBM415 | NVP LBM-415 | NVP-PDF-713 | PDF-713 | VIC-104959
Compound class:
Synthetic organic
|
|
References |
1. Anderegg TR, Jones RN, Quality Control Working Group. (2004)
Disk diffusion quality control guidelines for NVP-PDF 713: a novel peptide deformylase inhibitor. Diagn Microbiol Infect Dis, 48 (1): 55-7. [PMID:14761722] |
2. Jones RN, Moet GJ, Sader HS, Fritsche TR. (2004)
Potential utility of a peptide deformylase inhibitor (NVP PDF-713) against oxazolidinone-resistant or streptogramin-resistant Gram-positive organism isolates. J Antimicrob Chemother, 53 (5): 804-7. [PMID:15056649] |
3. Kosowska-Shick K, Credito KL, Pankuch GA, DeWasse B, McGhee P, Appelbaum PC. (2007)
Multistep resistance selection and postantibiotic-effect studies of the antipneumococcal activity of LBM415 compared to other agents. Antimicrob Agents Chemother, 51 (2): 770-3. [PMID:17116666] |
4. Sangshetti JN, Khan FA, Shinde DB. (2015)
Peptide deformylase: a new target in antibacterial, antimalarial and anticancer drug discovery. Curr Med Chem, 22 (2): 214-36. [PMID:25174923] |
5. Waites KB, Reddy NB, Crabb DM, Duffy LB. (2005)
Comparative in vitro activities of investigational peptide deformylase inhibitor NVP LBM-415 and other agents against human mycoplasmas and ureaplasmas. Antimicrob Agents Chemother, 49 (6): 2541-2. [PMID:15917568] |